Day: November 10, 2020

Sales of $609 million, flat compared to the prior-year quarterNet income of $5 million, or $0.07 per diluted shareIncome from continuing operations was zeroAdjusted income from continuing operations excluding intangibles amortization expense of $76 million, or $1.25 per diluted shareAdjusted EBITDA of $154 millionCash flows provided by operating activities of $160 million; free cash flows of $116 millionWILMINGTON, Del., Nov. 10, 2020 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced preliminary1 financial results for the fourth quarter of fiscal year 2020 which ended September 30, 2020. The global specialty materials company serves customers in a wide range of consumer and industrial markets.Ashland’s financial results during the quarter reflected both strong resiliency in demand and the positive impact...

TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will participate in three investor conferences in November.Jefferies Virtual London Healthcare Conference: Profound is scheduled to participate in a fireside chat on Tuesday, November 17, 2020 at 12:00 p.m. ET (5:00 p.m. GMT). The fireside chat will be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section.Canaccord Genuity Virtual MedTech & Diagnostics Forum:...

LONDON and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the Barclays Gene Editing & Gene Therapy Summit on Monday, November 16, 2020 at 1:30 p.m. ET.A live webcast of the presentation will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. A replay of the webcast will be available for approximately 30 days following the presentation.About MeiraGTxMeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and...

SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis, M.D., will present a company overview at the Jefferies Virtual London Healthcare Conference on Nov. 18.Dr. Countouriotis’ session is scheduled to begin at 12:35 p.m. ET and will be accessible via webcast through the Investors page of www.tptherapeutics.com.About Turning Point Therapeutics Inc.Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company’s lead drug candidate, repotrectinib, is a next-generation kinase inhibitor...

EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London Healthcare Conference.Details of the presentation are as follows:A live webcast of the fireside chat will be available under the “For Investors” section of the Antares Pharma website at www.antarespharma.com.About Antares PharmaAntares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various...

SUNNYVALE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) announced today that Tom Fallon, Chief Executive Officer, David Heard, Chief Operating Officer, and Nancy Erba, Chief Financial Officer, are scheduled to participate at the Needham Virtual Security, Networking, and Communications Conference and present on Tuesday, November 17, 2020 at 11:00 a.m. Eastern Time.A live webcast, as well as the replay, of these presentations will be accessible from the Investors section of the Infinera’s website at investors.infinera.com and selecting events.Contacts:Media:Anna VueTel. +1 (916) 595-8157avue@infinera.comInvestors:Amitabh Passiapassi@infinera.comMichael Bowen, ICR, Inc.Tel. +1 (203) 682-8299Michael.Bowen@icrinc.comMarc P. Griffin, ICR, Inc.Tel. +1 (646)-277-1290Marc.Griffin@icrinc.comAbout InfineraInfinera...

FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that company management will present at the Jefferies Virtual London Healthcare Conference on Tuesday November 17, 2020 at 12:35pm ET.A live webcast of the presentation can be accessed through the Investors & Media section of the Company’s website at http://investors.vaxcyte.com. A replay of the webcast will be available for approximately 30 days following the conference.About VaxcyteVaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to...